One of the most common birth defects in the world is hearing loss. Every 1,000 babies are born with permanent hearing loss in one or both ears. Hearing loss can have a significant impact on a baby's development.
CapitalBio created Hereditary #Deafness Gene Detection Item using semiconductor sequencing technology. It can identify #100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection is more than 99.9 percent accurate.
The Bioelectron gene sequencer 4000 platform was created in collaboration with Thermo Fisher. It can detect 384 samples at the same time.
Working Principle of Deep Resolution DNA Microarray ScannerApril 10, 2024As an important tool in modern biotechnology, DNA microarray scanners play a vital role in genomics, disease diagnosis, drug research and development, and other fields. They can achieve rapid and accu...view
What is In Vitro Diagnostic Reagents?April 4, 2023In vitro diagnostic reagents refer to in vitro diagnostic reagents managed by medical device management, including reagents, reagent kits, calibration products, quality control products, etc. used for...view
Development Status and Future of in Vitro Diagnostic TechnologyDecember 15, 2022In vitro diagnostic technology refers to products and services that obtain relevant clinical diagnostic information by testing samples of the body including blood, body fluids, and tissues outside the...view
Which is the Best Method for HLA Typing?March 11, 2024In the realm of immunogenetics, the significance of Human Leukocyte Antigen (HLA) typing cannot be overstated. It plays a pivotal role in various medical and research applications, including organ tra...view